What Is LL-37 Peptide?
LL-37 is a 37-amino-acid peptide derived from the C-terminal region of the human cathelicidin precursor hCAP18. It belongs to the cathelicidin family of cationic host-defense peptides. hCAP18 is encoded by the CAMP gene and is processed to release the mature LL-37 peptide.
LL-37 is the sole identified human cathelicidin. Its name refers to the mature 37-residue peptide, which begins with two leucine residues.
Research Overview Table
Chemical and Molecular Characteristics
LL-37 is a 37-amino-acid linear peptide with the molecular formula C205H340N60O53 and a molecular weight of 4,493 g/mol. It is a cationic peptide containing both hydrophobic and charged amino acid residues. PubMed literature characterizes LL-37 as an amphipathic, helical peptide.
The mature peptide has a defined 37-residue sequence and contains multiple ionizable amino acid side chains. Its chemical composition includes acidic, basic, polar, and hydrophobic residues within the same peptide chain. PubChem lists 68 hydrogen-bond donors, 65 hydrogen-bond acceptors and a topological polar surface area of 1,900 Ų as computed chemical descriptors.
Certificates:
Mechanism of Action Under Investigation
LL-37 has no single established molecular target. Its most extensively studied molecular interaction is with lipid membranes. Studies show that LL-37 associates with lipid bilayers through electrostatic and hydrophobic interactions. This association can alter lipid organization and membrane curvature and, under specific membrane conditions, produce membrane permeabilization. Studies have proposed different membrane-disruption models, including carpet-like and toroidal-pore mechanisms.
LL-37 has also been investigated as a modulator of P2X7 receptor activity. In P2X7-expressing cells, LL-37 has been reported to increase calcium influx and membrane permeability. Other studies have linked P2X7-associated LL-37 signaling with ERK and JNK activation and downstream COX-2 and PGE₂ production. These observations come from specific cell systems and do not establish P2X7 as the universal target of LL-37.
The exact mechanism remains uncertain because LL-37 produces different molecular responses in different membrane and cellular systems. Published studies therefore support multiple molecular interactions rather than one fully established mechanism of action.
Scientific Research Context
LL-37 has a long and fairly broad research history. Most of the published literature comes from in vitro studies and preclinical animal research, while human studies are less common. Early research established the peptide as a human cathelicidin, followed by studies using different laboratory and animal models. More recent research has also included clinical investigation. Even with this progression, preclinical studies still make up most of the available evidence.
LL-37 Biology and Biological Pathways
Primary Biological Function
LL-37 is the only human member of the cathelicidin family. It is produced mainly by epithelial cells and phagocytic immune cells and is found at sites such as the skin, respiratory tract, gastrointestinal tract, and genitourinary tract. Its established biological role is within innate host defense, where it contributes to interactions between epithelial tissues, immune cells, and microorganisms.
Relevant Metabolic or Signaling Pathways
Vitamin D–VDR signaling is a well-established pathway regulating CAMP, the gene encoding the LL-37 precursor. In human epithelial cells, 1,25-dihydroxyvitamin D₃ activates VDR, which regulates CAMP transcription through a vitamin D response element. C/EBPα also cooperates with VDR in CAMP regulation. Separately, ER stress has been shown to increase CAMP expression through an NF-κB–C/EBPα pathway independent of VDR.
Tissue-Specific Biology
LL-37 is expressed in epithelial tissues of the skin, gastrointestinal tract, respiratory tract, and genitourinary tract. Neutrophils and monocytes also produce LL-37, along with other immune and epithelial cell types. In the oral cavity, researchers have detected LL-37 in gingival epithelial cells, gingival tissue, gingival crevicular fluid and saliva. LL-37 expression therefore differs across tissues and cell types.
Experimental Biomarkers
LL-37 research commonly measures CAMP/LL-37 expression or peptide abundance together with related inflammatory and innate immune markers. Depending on the model, researchers have measured LL-37 mRNA, peptide levels, cytokines, chemokines, and other immune mediators. Gingival studies, for example, have measured LL-37 in gingival crevicular fluid and saliva.
Laboratory Investigation Methods
Researchers investigate LL-37 biology using cell culture, RT-PCR, qRT-PCR, immunohistochemistry, immunoblotting, and microscopy. These methods measure CAMP or LL-37 expression and examine its presence and localization in cells and tissues. Researchers have applied these approaches to epithelial cells, immune cells, and human tissue samples.
Experimental Models Used in Published Research
Established Human Cell Lines
LL-37 research has used established human cell lines, including epithelial and immune-cell lines. Their main limitation is that long-term cultured cells may differ from primary cells and do not reproduce the full cellular and structural environment of human tissues.
Primary Human Cells
Published studies have also used primary human epithelial and immune cells. These cells retain more donor specific characteristics than established cell lines. However, responses can vary between donors, and cells may change their properties during isolation and culture.
Human Tissue Samples
Human respiratory, intestinal, and oral tissues have been used as LL-37 research models. Their limitations include differences between tissue samples and donors, along with changes that can occur during tissue collection and preparation. These samples also cannot reproduce the complete physiological environment of an intact living organism.
Ex Vivo Tissue Models
Researchers use ex vivo human skin and tissue explants as LL-37 research models. Their main limitation is that they cannot fully reproduce the physiological conditions of living tissue after removal from the body.
Human Organoid Models
Human colon-derived epithelial organoids have been used as LL-37 research models. Their main limitation is that organoids remain simplified tissue models and do not fully reproduce the complexity of intact human tissue.
Mouse Models
LL-37 research includes mouse models, including models using human LL-37 and models involving CRAMP, the mouse cathelicidin homolog. The major limitation is the biological difference between mouse cathelicidin biology and human LL-37, which limits direct translation to humans.
Rat Models
Researchers have used rat models in LL-37 research, including Wistar and Sprague-Dawley rats. Their main limitation is differences between rat and human biology, including differences in cathelicidin biology, which limit direct translation of findings to human LL-37.
Rabbit Models
Rabbit hind-limb models have been used in LL-37 research. Their main limitation is that rabbit physiology and immune biology differ from humans, limiting direct translation of findings to human LL-37 biology..
Chorioallantoic Membrane Models
The chick chorioallantoic membrane (CAM) model has been used in LL-37 research. Its main limitation is that it is an avian extraembryonic tissue model, so it does not reproduce human tissue physiology.
LL-37 Published Research
Antimicrobial Activity
A major area of LL-37 research concerns its activity against bacteria, fungi, and viruses. Published studies have examined LL-37 across different microorganisms as part of research into human host-defense peptides.
Innate Immune and Inflammatory Biology
Published research has examined LL-37 in innate immune defense, inflammation, chemotaxis, and immune-cell responses. Studies have also investigated LL-37 in relation to cytokines, chemokines and microbial components.
LL-37 Expression and Regulation
Published research has examined CAMP expression and LL-37 production, including how these processes change in response to vitamin D, hypoxia related signaling, microbial exposure, and cellular stress.
Respiratory Biology
Published research has examined LL-37 in lung and airway biology, including pulmonary host defense, respiratory infection, airway epithelial responses, and inflammation.
Gastrointestinal and Oral Biology
Published research has examined LL-37 in intestinal and oral tissues, including its expression in epithelial tissues and its relationship with local immune and microbial environments.
Wound and Vascular Biology
Researchers have investigated LL-37 in wound biology, epithelial repair, angiogenesis, and vascular responses. This area includes both cellular and animal research.
Cancer Biology
The literature also contains research on LL-37 in cancer biology, including its relationship with tumor cells, the tumor microenvironment, inflammation, and angiogenesis.
Limitations of Current Research
Evidence Is Predominantly Preclinical
Most of the LL-37 literature is preclinical, with human clinical evidence making up a smaller part of the research base. This limits how confidently findings from laboratory and animal studies can be applied to human biology.
Human Clinical Evidence
Human clinical evidence for LL-37 is more limited than the broader preclinical literature. Existing studies focus on specific clinical settings, and differences in study populations, conditions, and outcomes make it difficult to draw broad conclusions across the available evidence.
Species Differences
Species differences limit how directly animal findings apply to human LL-37. LL-37 is the only cathelicidin found in humans, while other species produce distinct cathelicidin peptides. Differences between these peptides can affect their biological properties, so findings from animal cathelicidins may not directly reflect human LL-37 biology.
Study Design Limitations
Differences in experimental conditions, peptide concentrations, biological systems, and study design can make LL-37 findings difficult to compare across studies. These differences also make it harder to determine whether observations seen under one set of conditions apply consistently in other research settings.
Independent Replication
The strength of evidence varies between individual LL-37 research areas. Some findings have been examined across multiple studies, while other observations come from narrower experimental settings. Additional independent replication would help determine how consistently those findings apply across different research settings.
Long-Term Evidence
Long term human evidence on LL-37 remains limited. Animal studies have examined prolonged LL-37 exposure, but those findings cannot establish the effects of prolonged exposure in humans.
Analytical Documentation
HPLC can assess LL-37 chromatographic purity and profile. LC-MS can support identity confirmation through molecular-mass measurement and detection of related molecular species.
NMR can provide structural information about LL-37 and has been used to characterize its structure under defined experimental conditions.
A Certificate of Analysis (CoA) provides batch-specific analytical information, such as reported identity, purity, test results, and the methods used for testing.
Analytical documentation helps establish the identity and stated quality of the material used in laboratory research. It verifies product identity and quality, not biological performance.
Storage and Laboratory Handling
Store LL-37 according to the product-specific storage specifications. The provided Certificate of Analysis lists 2–8°C.
Keep the material properly sealed during storage and handling to reduce contamination. Qualified laboratory personnel should handle the material using appropriate laboratory practices.
Maintain the specified storage conditions throughout laboratory storage and avoid unnecessary exposure to conditions that could affect the material.
Frequently asked questions
Why choose us?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.